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Objective: To study the human migration inhibitory factor (MIF) level in tuberculosis (TB)
patients, and the relationship between MIF-794CATT microsatellite polymorphism and sus-
ceptibility of TB in Southwest China.
Methods: TB patients (n=151) and healthy unrelated controls (n=149) were recruited for this
study. Genomic DNA was extracted, and then ampliﬁed by polymerase chain reaction (PCR).
MIF-794CATT5-8 microsatellite polymorphism was genotyped by DNA sequencing. MIF level
was detected by ELISA.
Results: In the TB group, the repeat number of 7/7 and 7/8 (17.89%) was signiﬁcantly higher
than that of the control group (8.05%), and the serum MIF level was also much higher than
that of the healthy controls (705.21± 67.98 vs. 355.31± 57.29 pg/mL, p<0.01).
usceptibility Conclusion: The appearance of MIF-794CATT 7/7 and 7/8 is associated with susceptibility to
TB, and may play an important role in the occurrence and development of TB in Southwest
China.
12 Elntroduction
uberculosis (TB), which is a chronic infectious disease caused
y Mycobacterium tuberculosis (MTB), is a serious threat to
umanhealth. According to theWHOsurvey, there are an esti-
ated 14 million TB patients globally, while nearly 1.7 million
eople die of TB each year.1 Currently, about 130,000 people
ie of TB and 1.45 million new patients are diagnosed with TB
© 20ach year in China, which has the second highest number of
B patients in the world. Thus, prevention and control of TB
s attracting more and more attention of the medical world.
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Este é um artigo Open Access sob a licençaStudies have conﬁrmed that besides environmental factors
and individual differences, genetic susceptibility genes also
play a role in the development of TB.2 The study by Fontaine
et al. found that human migration inhibitory factor (MIF)
genetic variantswere associatedwith susceptibility to autoim-
mune disease.3 In an in vitro study, Gómez et al. reported
that MIF played an important role in inhibiting the growth
of pathogenic MTB in macrophages by acting in an autocrine
fashion.4 The MIF gene is located on human chromo-
sevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDt, Chongqing, China.
some 22q11.2. Two polymorphisms with potential functional
relevance have been reported in the MIF promoter: SNP -
173G/C and microsatellite polymorphism -794CATT5-8. The C
 de CC BY-NC-ND
i s . 20384 braz j infect d
genotype of MIF-173 was found in this study to be associated
with TB. The relationship between MIF-794CATT microsatel-
lite polymorphism and susceptibility of TB was further
investigated in the present study.
Materials and methodsSubjects
Cases were recruited from patients who were diagnosed
with TB at the Third Afﬁliated Hospital of the Third Military
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Fig. 1 – Number of the CATT sequenc12;16(4):383–386
Medical University and at the TB Prevention and Treatment
Center in Chongqing (Chongqing, China) from December, 2009
to December, 2010. 151 TB patients (83 males and 68 females,
mean age 47.8± 5.76 years) and 149 healthy unrelated con-
trols (61 males and 88 females, mean age 40.2± 4.9 years)
were included in the present study, and everyone in the con-
trol group was in-patient at the Third Afﬁliated Hospital of
the Third Military Medical University. Diagnosis of TB was
based on the identiﬁcation of acid-fast bacilli (AFB) in sputum
samples and chest X-ray examination. Exclusion criteriawere:
hypertension, diabetes, thyroid disease, liver disease, kidney
80
80 90
90 100
80 90
ed repeats: A 5, B 6, C 7 and D 8.
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Fig. 2 – Frequencies of MIF-794CATT5-8 genotype and allele
between tuberculosis patients and healthy controls
(p<0.05).braz j infect d i s .
isease, cancer, chronic wasting disease, and infection of the
eart, brain, kidney, or lung.
uman genomic DNA extraction
enomic DNA was extracted from peripheral blood anticoag-
lant with EDTA-K2 by a commercially available blood DNA
xtraction kit (Tiangen Company, Beijing, China) according to
nstructions. Then the isolated DNA was stored in TE solution,
rozen at -20◦C for use.
IF-794CATT5-8 genotyping
rimers were designed to amplify a 169bp (CATT6)
egment of the MIF promoter region containing the
icrosatellite repeat sequence. The upstream primer was 5’-
TATCAGAGACCAAGGACAG-3’, and the downstream primer
as 5’ -CCAGGCATATCAAGAGACAT-3’. The PCR reaction
onditions were as follows: denaturation at 95◦C for 10min,
5 cycles of 95◦C for 45 sec, 57◦C for 40 sec, 72◦C for 45 sec,
ollowed by a seven-minute extension at 72◦C. The unpu-
iﬁed PCR products were sent directly to the Biology CRO
f the Nanjing GenScript Corporation for sequencing. The
equencing primers were the same as those of PCR.
nalysis of serum MIF levels
lood serumwas separated from3mLof peripheral blood from
he TB patients and from the control group, and then stored
t -20 ◦C for MIF levels testing with ELISA kits (R&D, USA).
tatistical analysis
he sequencing results were analyzed by Primer 6.0. Hardy-
einberg equilibrium was used for testing the allele and
enotype distribution. The frequencies for the TB patients and
ontrol-group individuals were statistically compared using
he chi-squared test with the Statistical Package for Social
ciences (SPSS) 17.0 software, and MIF levels were compared
sing Student’s t-test. A p-value<0.05 was considered statis-
ically signiﬁcant.
esults
IF-794CATT5-8 polymorphism analysis
eripheral blood genomic DNA was extracted from 151 con-
rmed TB patients and 149 controls. The sequencing analysis
esults of the MIF gene promoter -794 polymorphism are
hown in Fig. 1. The results reveal that there are ﬁve to eight
ATT repeats sequenced in each single-stranded DNA. The
requency distribution of the MIF gene -794CATT5-8 allele is
hown in Fig. 2, which shows that the percentage of the MIF
794CATT with the repeat number 7/7 and 7/8 is 17.89% in TB
roup patients, which is signiﬁcantly higher than the 8.05% of
he control group (p<0.05, OR=2.49).Serum MIF levels
The serum MIF levels of TB patients and normal controls were
705.21± 67.98 and355.31± 57.29pg/mL, respectively. Theaver-
age MIF level of the TB patients was almost twice as high as
that of the healthy control group (p<0.01).
Discussion
Gene polymorphism plays an important role in the occur-
rence and development of TB. Several TB susceptibility
genes have been discovered, such as natural resistance
associated macrophage protein-1 (Nramp1) gene,5 human
leukocyte antigen (HLA) gene,6 vitamin D receptor (VDR)
gene,7 SP110 nuclear body protein gene (SP110),8 mannose
binding lectin (MBL) gene,9 nitric oxide synthase 2 gene
(NOS2A),10 and IFN- gene (IFNG).10 Therefore, studies on the
relationship between gene polymorphism and TB susceptibil-
ity are of great signiﬁcance in the prevention and treatment
of TB.
MIF is a protein consisting of 115 amino acidswith amolec-
ular weight of 12.5 kDa. Because of its wide expression in
various cells, MIF is considered to be a versatile cytokine.
Recently, many studies have reported that MIF is not only a
T cell-derived cytokine, but could also be released from other
cells such as monocyte-macrophage cells and anterior pitu-
itary cells. The results of this study conﬁrm that MIF-794CATT
7/7 and 7/8 genotypes are associated with the susceptibility
of TB (OR=2.49). The ratio of the genotype CATT5+6 in TB
patients group is 64.57%,which is lower than the control group
(74.5%), indicating that CATT5+6 may inhibit the susceptibility
of TB.
This study also conﬁrms that the MIF level of TB patients
is signiﬁcantly higher than that of the healthy controls. The
MIF-794CATT5-8 microsatellite polymorphism has been found
to be associated with the alteration of MIF gene transcription
levels in vitro.11 The repeat number of the CATT can regulate
the activity of MIF gene promoter. The higher the repeat num-
ber, the stronger the activity of the promoter. In vitro, MIF can
i s . 20
r
1
1386 braz j infect d
inhibit the growth of pathogenic Mycobacterium tuberculosis.12
However, it is speculated that, when the body is infected with
M. tuberculosis, it is supposed to be any mechanisms which
could induce MIF loss or weaken the inhibition of M. tubercu-
losis. In short, the mechanism of MIF in the development of
TB remains unclear, and further experimental studies are still
needed to conﬁrm it.
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